Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signaling
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2417252121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Tal Yardeni und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104. Hauptthemen laut MEDLINE: Reactive Oxygen Species, T-Lymphocytes, Regulatory, DNA, Mitochondrial, Mice, Inbred C57BL. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | NCI | Division of Cancer Epidemiology and Genetics (DCEG), NIA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Mitochondrial DNA (mtDNA) is highly polymorphic, and host mtDNA variation has been associated with altered cancer severity. To determine the basis of this mtDNA–cancer association, we analyzed conplastic mice with the C57BL/6J (B6) nucleus but two naturally occurring mtDNA lineages, mtDNA B6 and mtDNA NZB , where mtDNA NZB mitochondria generate more oxidative phosphorylation (OXPHOS)-derived reactive oxygen species (mROS). In a cardiac transplant model, mtDNA B6 Foxp3+ T regulatory (Treg) cells supported long-term allograft survival, whereas mtDNA NZB Treg cells failed to suppress host T effector (Teff) cells, leading to acute rejection. When challenged with melanoma or colon cancer cells, the mtDNA NZB mice exhibited strikingly impaired tumor growth while mtDNA B6 mice showed Treg-dependent inhibition of Teff cells and allowed rapid tumor growth. Transcriptional analysis showed that activation of mtDNA NZB Teff cells increased mitochondrial gene expression while activation of mtDNA NZB Treg cells impaired mitochondrial gene expression and resulted in mtDNA NZB Treg cell exhaustion. Induction of the mitochondrially targeted catalytic antioxidant, mCAT, in hematopoietic cells normalized mtDNA NZB Treg function in both transplant and tumor models, indicating a key role for mROS in promoting Treg dysfunction. Anti-PD-L1 therapy did not modulate these effects, indicating that modulation of host mitochondrial function provides an independent approach for enhancing tumor cell destruction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
- Bert Strassburger Metabolic Center for Preventive Medicine, Sheba Medical Center, Tel Hashomer 5262000, Israel.
- Division of Transplant Immunology, Children's Hospital of Philadelphia and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104.
- Division of Human Genetics, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
- Department of Developmental and Cell Biology, Charlie Dunlop School of Biological Sciences, University of California, Irvine, CA 92697-2300.
- Division of Oncology, Sheba Medical Center, Tel-Hashomer, Tel-Aviv University, Tel Aviv 5262000, Israel.
ORCID-Profile: Ben Boursi, Wayne W Hancock, Douglas C Wallace
Förderung
- HHS | NIH | NCI | Division of Cancer Epidemiology and Genetics (DCEG)
- NIA NIH HHS
- NCI NIH HHS
- HHS | NIH | National Institute on Aging (NIA)
- HHS | NIH | National Cancer Institute (NCI)
Zitieren
APA
Yardeni, T., Olali, A. Z., Chen, H. W., Wang, L., Haltom, J. A., Zenab, A., Morrow, R., Butic, A., Murdock, D. G., Waymire, K. G., MacGregor, G. R., Boursi, B., Beier, U. H., Hancock, W. W., & Wallace, D. C. (2025). Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signaling. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2417252121
Vancouver
Yardeni T, Olali AZ, Chen HW, Wang L, Haltom JA, Zenab A, et al. Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signaling. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2417252121
BibTeX
@article{Yardeni2025,
author = {Yardeni, Tal and Olali, Arnold Z and Chen, Hsiao-Wen and Wang, Liqing and Haltom, Jeffrey A and Zenab, Angi and Morrow, Ryan and Butic, Arrienne and Murdock, Deborah G and Waymire, Katrina G and MacGregor, Grant R and Boursi, Ben and Beier, Ulf H and Hancock, Wayne W and Wallace, Douglas C},
title = {Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signaling},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2417252121}
}
EUVIMED